Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium chloride + sodium lactate + calcium chloride + potassium chloride + dextrose is a **multi-electrolyte intravenous crystalloid solution** used for parenteral replacement of extracellular fluid and electrolytes and as a source of water, electrolytes, and limited carbohydrate calories. It is marketed as **Lactated Ringer's and Dextrose** or **Dextrose in Lactated Ringers** and has been manufactured by companies including **Pfizer** and **ICU Medical**. Pharmacologically, it does not act through a single discrete molecular target; instead, sodium, potassium, calcium, chloride, lactate, and dextrose collectively restore intravascular and interstitial fluid composition, support acid-base balance through metabolism of lactate to bicarbonate, and provide modest caloric support through dextrose. It is administered as an **intravenous solution for injection/infusion** in adults and pediatric patients requiring fluid and electrolyte replacement or alkalinization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + sodium lactate + calcium chloride + potassium chloride + dextrose.